Atom | Pfizer Quality Improvement Request for Proposals: Optimizing Clinical Care Delivery for Patients with Multiple Myeloma Receiving Bispecific Antibodies

Due Dates: May 8, 2026: Submission deadline (full application) - applications due by 23:59 Eastern Standard Time

Funding Amounts: Up to 40,000€ per project; total program budget approx. 130,000€; project duration up to 18 months

Summary: Supports quality improvement projects to optimize and standardize care for Multiple Myeloma patients in Spain receiving bispecific antibodies.

Key Information: Only organizations in Spain are eligible; clinical research projects are not supported.

Pfizer Quality Improvement Request for Proposals: Optimizing Clinical Care Delivery for Patients with Multiple Myeloma Receiving Bispecific Antibodies

Sign in to see full grant listing